2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
Albers G, Jumaa M, Purdon B, Zaidi S, Streib C, Shuaib A, Sangha N, Kim M, Froehler M, Schwartz N, Clark W, Kircher C, Yang M, Massaro L, Lu X, Rippon G, Broderick J, Butcher K, Lansberg M, Liebeskind D, Nouh A, Schwamm L, Campbell B. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection. New England Journal Of Medicine 2024, 390: 701-711. PMID: 38329148, DOI: 10.1056/nejmoa2310392.Peer-Reviewed Original ResearchConceptsModified Rankin ScaleSymptomatic intracranial hemorrhageInternal carotid arteryMiddle cerebral arteryRankin ScalePlacebo groupTenecteplase groupIntracranial hemorrhageIncidence of symptomatic intracranial hemorrhageCerebral arteryIncidence of symptomatic intracerebral hemorrhageCarotid arteryPlacebo-controlled trialSymptomatic intracerebral hemorrhageEvidence of occlusionSafety populationDouble-blindPerfusion-imagingMedian timeClinical outcomesIntracerebral hemorrhagePlaceboPerfusion imagingPrimary outcomeOdds ratio
2014
Exposing Hidden Truncation-Related Errors in Acute Stroke Perfusion Imaging
Copen W, Deipolyi A, Schaefer P, Schwamm L, González R, Wu O. Exposing Hidden Truncation-Related Errors in Acute Stroke Perfusion Imaging. American Journal Of Neuroradiology 2014, 36: 638-645. PMID: 25500309, PMCID: PMC7964314, DOI: 10.3174/ajnr.a4186.Peer-Reviewed Original ResearchConceptsPerfusion scanVolume of lesionsScan durationSymptom onsetAcute infarctsHemodynamic measurementsLesion reversalClinical trialsLesion volumePatient managementPerfusion MRPerfusion imagingInjected contrast agentPerfusion imagesPatient CTLesionsDurationMTTCTLong scan durationScansContrast agentsShort scan durationTmaxPerfusion estimates
2012
Economic Impact of Using Additional Diagnostic Tests to Better Select Patients With Stroke for Intravenous Thrombolysis in the United Kingdom
Earnshaw S, McDade C, Chapman A, Jackson D, Schwamm L. Economic Impact of Using Additional Diagnostic Tests to Better Select Patients With Stroke for Intravenous Thrombolysis in the United Kingdom. Clinical Therapeutics 2012, 34: 1544-1558. PMID: 22695225, DOI: 10.1016/j.clinthera.2012.05.004.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingMRI selectionUsual careDiagnostic testsFavorable outcomeIncremental cost-effectiveness ratioAcute stroke treatmentPreferred diagnostic testNumber of patientsAdditional diagnostic testsCost-effectiveness ratioDecision analytic modelCTP selectionIntravenous thrombolysisStroke onsetStroke treatmentPatient selectionUK patientsPenumbral patternPatient outcomesPerfusion CTPatient historyThrombolysisPatientsPerfusion imaging
2008
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Hacke W, Furlan A, Al-Rawi Y, Davalos A, Fiebach J, Gruber F, Kaste M, Lipka L, Pedraza S, Ringleb P, Rowley H, Schneider D, Schwamm L, Leal J, Söhngen M, Teal P, Wilhelm-Ogunbiyi K, Wintermark M, Warach S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. The Lancet Neurology 2008, 8: 141-150. PMID: 19097942, PMCID: PMC2730486, DOI: 10.1016/s1474-4422(08)70267-9.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBrain IschemiaCerebral HemorrhageDouble-Blind MethodFemaleFibrinolytic AgentsHumansInjections, IntravenousMagnetic Resonance ImagingMaleMiddle AgedPerfusionPlasminogen ActivatorsProspective StudiesSample SizeStrokeTomography, X-Ray ComputedTreatment FailureYoung AdultConceptsSymptomatic intracranial hemorrhageClinical response rateAcute ischemic strokeDiffusion-weighted imagingResponse rateNIHSS scoreIschemic strokeIntracranial hemorrhageLesion volumeDay 90Mortality ratePerfusion imagingScale scoreHealth Stroke Scale scoreMedian baseline NIHSS scoreModified Rankin Scale scoreMagnetic resonance perfusion imagingComposite of improvementBaseline NIHSS scorePlacebo-controlled studyStroke Scale scoreDose-ranging studyRankin Scale scoreSymptoms of strokeOnset of stroke
2001
CT Perfusion Imaging versus MR Diffusion Weighted Imaging: Prediction of Final Infarct Size in Hyperacute Stroke
Berzin T, Lev M, Goodman D, Koroshetz W, Hunter G, Hamberg L, Buonanno F, Putman C, Budzik R, Eskey C, Schwamm L, Gonzalez R. CT Perfusion Imaging versus MR Diffusion Weighted Imaging: Prediction of Final Infarct Size in Hyperacute Stroke. Stroke 2001, 32: 317-317. DOI: 10.1161/str.32.suppl_1.317.Peer-Reviewed Original ResearchFinal infarct sizeCT perfusion imagingInfarct sizeStroke onsetHyperacute strokeDWI volumePerfusion imagingFinal infarct volumeBrain CT scanningHyperacute stroke patientsSame patient populationMR-Diffusion Weighted ImagingSteady-state administrationCT angiographic imagesDiffusion-Weighted ImagingDWI imagingInfarct volumeConsecutive patientsIndependent predictorsIschemic volumeStroke patientsPatient populationCTP imagingBlood volumePatients